Skip to main navigation Skip to search Skip to main content

Aztreonam plus vancomycin (plus amikacin) vs. moxalactam plus ticarcillin for the empiric treatment of febrile episodes in neutropenic cancer patients.

P. Jones, K. Rolston, V. Fainstein, L. Elting, G. P. Bodey

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Aztreonam plus vancomycin (plus amikacin) vs. moxalactam plus ticarcillin for the empiric treatment of febrile episodes in neutropenic cancer patients.'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science